ACTIVITY DETAILS

Schizophrenia: Treating a Chronic Disease with a Focus on Early Intervention, Adherence, and Recovery

neuroscienceCME Live and On Demand
Premiere Date: Wednesday, August 12, 2009

Click here to access additional resources mentioned in the live broadcast.
This activity offers CE credit for:

Physicians (ACCME/AMA PRA Category 1)
Nurses (CNE)
Pharmacists (ACPE)
Psychologists (APA)
Social Workers (NASW)
Certified Case Managers (CCMC)
All other clinicians will either receive a CME Attendance Certificate or may choose any of the types of CE credit being offered.
Credit Expiration Date:
Thursday, August 12, 2010

Faculty

John W. Newcomer, MD (Moderator)
Gregory B. Couch Professor of Psychiatry, Psychology and Medicine
Director, Clinical Trials Unit, Institute of Clinical and Translational Sciences (ICTS)
Director, Regulatory Support Center, ICTS
Medical Director, Center for Clinical Studies
Washington University School of Medicine
St. Louis, MO

Diana O. Perkins, MD, MPH
Professor, Department of Psychiatry
Medical Director, Outreach and Support Intervention Services (OASIS)
University of North Carolina
Chapel Hill, NC

Alexander S. Young, MD, MSHS
Professor, UCLA Department of Psychiatry
Director, Health Services
VA Desert Pacific Mental Illness Research, Education and Clinical Center
Los Angeles, CA

Statement of Need

Schizophrenia is notable for its substantial impact on everyday functioning, being one of the top five causes of disability in individuals under the age of 25. In most cases, individuals who develop schizophrenia manifest behavioral changes prior to the formal diagnosis of the condition. These changes, referred to as the "prodrome," are variable across individuals who may eventually develop schizophrenia.(1,2) Proactive risk assessment in other chronic diseases such as cardiovascular disease, diabetes mellitus, and cancer has brought about advances in early detection and intervention leading to substantial reductions in morbidity, mortality, and improved quality of life. It is imperative that this type of proactive intervention becomes part of timely diagnosis and better outcomes for patients with schizophrenia.

Clinicians face challenges designing treatment plans for patients with schizophrenia that will maximize adherence and reduce side effects. Relapse rates tend to be quite predictable, can be affected by adherence, and have multiple adverse consequences. Minimizing relapse requires a coordinated effort between the patient, provider, family, and multidisciplinary treatment team. In this interactive neuroscienceCME activity, faculty will focus on the impact of treatment selection, phase of illness, medication adherence, and side effect burden on the journey toward remission and recovery in schizophrenia.

Cannon TD, et al. Arch Gen Psychiatry 2008;65:28-37.
Correll CU, et al. J Child Adolesc Psychopharmacol 2005;15:418-433.

Activity Goal

To identify and utilize evidence-based management strategies to improve outcomes for patients with schizophrenia.

Learning Objectives

At the end of this CE activity, participants should be able to:

Utilize available tools and evidence base to improve early recognition of schizophrenia.
Identify the key considerations that may impact adherence and outcomes when creating a treatment plan.
Create a treatment plan that includes patients, families, and the treatment team and utilizes the Competency Assessment Instrument to focus on recovery.

The following learning objectives pertain only to those requesting CNE credit:

Identify available tools and evidence base to improve early recognition of schizophrenia.
Identify the key considerations that may impact adherence and outcomes when creating a treatment plan.
Identify critical elements of a treatment plan that includes patients, families, and the treatment team and utilizes the Competency Assessment Instrument (CAI) to focus on recovery.

Target Audience

Physicians, physician assistants, nurse practitioners, nurses, psychologists, social workers, certified case managers, pharmacists, and other healthcare professionals with an interest in mental health.

Financial Support

This activity is supported by an educational grant from Lilly USA, LLC. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.

This CME/CE-certified activity is funded by CME Outfitters, LLC, and supported by an educational grant from Pfizer Inc.

Credit Information

CME Credit (Physicians):
The University of Texas Southwestern Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Texas Southwestern Medical Center designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Note to Physician Assistants: AAPA accepts Category I credit from AOACCME, Prescribed credit from AAFP, and AMA Category I CME credit for the PRA from organizations accredited by ACCME.

CNE Credit (Nurses):
This continuing nursing education activity was approved by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

It has been assigned approval code 7YDSRT-10. 1.0 contact hours will be awarded upon successful completion.

CEP Credit (Psychologists):
CME Outfitters is approved by the American Psychological Association to sponsor continuing education for psychologists. CME Outfitters maintains responsibility for this program and its content. (1.0 CE credits)

NASW Credit (Social Workers):
This program was approved by the National Association of Social Workers (provider #886407722) for 1 continuing education contact hour.

CCMC Credit (Certified Case Managers):
This program has been approved for 1 hour by the Commission for Case Manager Certification (CCMC).

CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.0 contact hours (0.1 CEUs)
Universal Program Number: 376-999-09-019-L01-P (live presentation) 376-999-09-019-H01-P (recorded programs)
Activity Type: knowledge-based

Post-tests, credit request forms, and activity evaluations can be completed online at www.neuroscienceCME.com (click on the Testing/Certification link under the Activities tab—requires free account activation), and participants can print their certificate or statement of credit immediately (70% pass rate required). Otherwise, participants should fully complete and return both the credit request form and activity evaluation located within the course guide for this activity. A certificate or statement of credit will be mailed within 4–6 weeks to all who successfully complete these requirements. This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit www.neuroscienceCME.com/technical.asp.

This continuing education activity is co-sponsored by The University of Texas Southwestern Medical Center and CME Outfitters, LLC.

Disclosure Declaration

It is the policy of The University of Texas Southwestern Medical Center and CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. All decisions to invite faculty were made by The University of Texas Southwestern Medical Center and CME Outfitters, LLC, independent of any commercial interest. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. The University of Texas Southwestern Medical Center and CME Outfitters, LLC, have evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Newcomer has disclosed that he receives grant support from The National Institute of Mental Health, The National Alliance for Research on Schizophrenia and Depression, Bristol-Myers Squibb Company, Janssen, L.P.; Pfizer Inc., and Wyeth Pharmaceuticals. He serves as a consultant to AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, litigation regarding medication effects, GlaxoSmithKline, H. Lundbeck A/S, Janssen, L.P., Organon Pharmaceuticals USA Inc., Otsuka America Pharmaceutical, Inc., Pfizer Inc., Solvay Pharmaceuticals, Inc., Tikvah Therapeutics, Inc., VANDA Pharmaceuticals, and Wyeth Pharmaceuticals. He serves on the data safety monitoring committee of Dainippon Sumitomo Pharma America, Inc., Organon Pharmaceuticals USA Inc., Schering-Plough Corporation, and Vivus, Inc. Dr. Newcomer also receives product development royalties for Metabolic Screening forms from Compact Clinicals/Jones and Bartlett Publishing.

Dr. Perkins has disclosed that she receives grant/research support from Janssen, L.P. She serves as a consultant to Dainippon Sumitomo Pharma. She is on the speakers bureau for Eli Lilly and Company.

Dr. Young has no disclosures to report.

Unlabeled Use Disclosure

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

The University of Texas Southwestern Medical Center, CME Outfitters, LLC, the faculty, Lilly USA, LLC, and Pfizer Inc. do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.

Questions about this activity? Call us at 877.CME.PROS (877.263.7767).

TV-061-081209-90